Selected research
Market Structure
Global AI Disease Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Disease Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Disease Detection include Nuvoola, Oatmeal Health, NIRAMAI, iCAD, MultiplAI Health, Medicus AI, AEYE Health, NURA and Kheiron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Disease Detection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Disease Detection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Disease Detection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Disease Detection market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Disease Detection Segment by Company
Nuvoola
Oatmeal Health
NIRAMAI
iCAD
MultiplAI Health
Medicus AI
AEYE Health
NURA
Kheiron
Aidoc
Aiberry
Ellipsis Health
Omdena
Innowise Group
Syndell
Klizo Solutions
Wysa
AI Disease Detection Segment by Type
Physical Ailment
Mental Illness
AI Disease Detection Segment by Application
Hospital
Enterprise
Individual
Others
AI Disease Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Disease Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Disease Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Disease Detection industry.
Chapter 3: Detailed analysis of AI Disease Detection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Disease Detectionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Physical Ailment
- Mental Illness
Applications
- Hospital
- Enterprise
- Individual
- Others
Companies covered
- Nuvoola
- Oatmeal Health
- NIRAMAI
- iCAD
- MultiplAI Health
- Medicus AI
- AEYE Health
- NURA
- Kheiron
- Aidoc
- Aiberry
- Ellipsis Health
- Omdena
- Innowise Group
- Syndell
- Klizo Solutions
- Wysa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Disease Detection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Physical Ailment
- 1.2.3 Mental Illness
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Disease Detection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Enterprise
- 1.3.4 Individual
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Disease Detection Growth Trends by Region
- 1.5.1 Global AI Disease Detection Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Disease Detection Market Size by Region (2021-2026)
- 1.5.3 AI Disease Detection Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Disease Detection Market Dynamics
- 2.1 AI Disease Detection Industry Trends
- 2.2 AI Disease Detection Industry Drivers
- 2.3 AI Disease Detection Industry Opportunities and Challenges
- 2.4 AI Disease Detection Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Disease Detection Revenue by Company (2021-2026)
- 3.2 Global AI Disease Detection Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Disease Detection Key Company Head office and Area Served
- 3.4 Global AI Disease Detection Company, Product Type & Application
- 3.5 Global AI Disease Detection Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Disease Detection Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Disease Detection Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Disease Detection Tier 1, Tier 2, and Tier 3
4 AI Disease Detection Market by Type
- 4.1 Global AI Disease Detection Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Disease Detection Market Size by Type (2021-2032)
- 4.3 Global AI Disease Detection Market Size Share by Type (2021-2032)
5 AI Disease Detection Market by Application
- 5.1 Global AI Disease Detection Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Disease Detection Market Size by Application (2021-2032)
- 5.3 Global AI Disease Detection Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Nuvoola
- 6.1.1 Nuvoola Company Information
- 6.1.2 Nuvoola Business Overview
- 6.1.3 Nuvoola AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Nuvoola AI Disease Detection Product Portfolio
- 6.1.5 Nuvoola Recent Developments
- 6.2 Oatmeal Health
- 6.2.1 Oatmeal Health Company Information
- 6.2.2 Oatmeal Health Business Overview
- 6.2.3 Oatmeal Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Oatmeal Health AI Disease Detection Product Portfolio
- 6.2.5 Oatmeal Health Recent Developments
- 6.3 NIRAMAI
- 6.3.1 NIRAMAI Company Information
- 6.3.2 NIRAMAI Business Overview
- 6.3.3 NIRAMAI AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 NIRAMAI AI Disease Detection Product Portfolio
- 6.3.5 NIRAMAI Recent Developments
- 6.4 iCAD
- 6.4.1 iCAD Company Information
- 6.4.2 iCAD Business Overview
- 6.4.3 iCAD AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 iCAD AI Disease Detection Product Portfolio
- 6.4.5 iCAD Recent Developments
- 6.5 MultiplAI Health
- 6.5.1 MultiplAI Health Company Information
- 6.5.2 MultiplAI Health Business Overview
- 6.5.3 MultiplAI Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 MultiplAI Health AI Disease Detection Product Portfolio
- 6.5.5 MultiplAI Health Recent Developments
- 6.6 Medicus AI
- 6.6.1 Medicus AI Company Information
- 6.6.2 Medicus AI Business Overview
- 6.6.3 Medicus AI AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Medicus AI AI Disease Detection Product Portfolio
- 6.6.5 Medicus AI Recent Developments
- 6.7 AEYE Health
- 6.7.1 AEYE Health Company Information
- 6.7.2 AEYE Health Business Overview
- 6.7.3 AEYE Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AEYE Health AI Disease Detection Product Portfolio
- 6.7.5 AEYE Health Recent Developments
- 6.8 NURA
- 6.8.1 NURA Company Information
- 6.8.2 NURA Business Overview
- 6.8.3 NURA AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 NURA AI Disease Detection Product Portfolio
- 6.8.5 NURA Recent Developments
- 6.9 Kheiron
- 6.9.1 Kheiron Company Information
- 6.9.2 Kheiron Business Overview
- 6.9.3 Kheiron AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Kheiron AI Disease Detection Product Portfolio
- 6.9.5 Kheiron Recent Developments
- 6.10 Aidoc
- 6.10.1 Aidoc Company Information
- 6.10.2 Aidoc Business Overview
- 6.10.3 Aidoc AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Aidoc AI Disease Detection Product Portfolio
- 6.10.5 Aidoc Recent Developments
- 6.11 Aiberry
- 6.11.1 Aiberry Company Information
- 6.11.2 Aiberry Business Overview
- 6.11.3 Aiberry AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Aiberry AI Disease Detection Product Portfolio
- 6.11.5 Aiberry Recent Developments
- 6.12 Ellipsis Health
- 6.12.1 Ellipsis Health Company Information
- 6.12.2 Ellipsis Health Business Overview
- 6.12.3 Ellipsis Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Ellipsis Health AI Disease Detection Product Portfolio
- 6.12.5 Ellipsis Health Recent Developments
- 6.13 Omdena
- 6.13.1 Omdena Company Information
- 6.13.2 Omdena Business Overview
- 6.13.3 Omdena AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Omdena AI Disease Detection Product Portfolio
- 6.13.5 Omdena Recent Developments
- 6.14 Innowise Group
- 6.14.1 Innowise Group Company Information
- 6.14.2 Innowise Group Business Overview
- 6.14.3 Innowise Group AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Innowise Group AI Disease Detection Product Portfolio
- 6.14.5 Innowise Group Recent Developments
- 6.15 Syndell
- 6.15.1 Syndell Company Information
- 6.15.2 Syndell Business Overview
- 6.15.3 Syndell AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Syndell AI Disease Detection Product Portfolio
- 6.15.5 Syndell Recent Developments
- 6.16 Klizo Solutions
- 6.16.1 Klizo Solutions Company Information
- 6.16.2 Klizo Solutions Business Overview
- 6.16.3 Klizo Solutions AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Klizo Solutions AI Disease Detection Product Portfolio
- 6.16.5 Klizo Solutions Recent Developments
- 6.17 Wysa
- 6.17.1 Wysa Company Information
- 6.17.2 Wysa Business Overview
- 6.17.3 Wysa AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Wysa AI Disease Detection Product Portfolio
- 6.17.5 Wysa Recent Developments
7 North America
- 7.1 North America AI Disease Detection Market Size (2021-2032)
- 7.2 North America AI Disease Detection Market Size by Type
- 7.2.1 North America AI Disease Detection Market Size by Type (2021-2026)
- 7.2.2 North America AI Disease Detection Market Size by Type (2027-2032)
- 7.2.3 North America AI Disease Detection Market Share by Type (2021-2032)
- 7.3 North America AI Disease Detection Market Size by Application
- 7.3.1 North America AI Disease Detection Market Size by Application (2021-2026)
- 7.3.2 North America AI Disease Detection Market Size by Application (2027-2032)
- 7.3.3 North America AI Disease Detection Market Share by Application (2021-2032)
- 7.4 North America AI Disease Detection Market Size by Country
- 7.4.1 North America AI Disease Detection Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Disease Detection Market Size by Country (2021-2026)
- 7.4.3 North America AI Disease Detection Market Size by Country (2027-2032)
- 7.4.4 North America AI Disease Detection Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Disease Detection Market Size (2021-2032)
- 8.2 Europe AI Disease Detection Market Size by Type
- 8.2.1 Europe AI Disease Detection Market Size by Type (2021-2026)
- 8.2.2 Europe AI Disease Detection Market Size by Type (2027-2032)
- 8.2.3 Europe AI Disease Detection Market Share by Type (2021-2032)
- 8.3 Europe AI Disease Detection Market Size by Application
- 8.3.1 Europe AI Disease Detection Market Size by Application (2021-2026)
- 8.3.2 Europe AI Disease Detection Market Size by Application (2027-2032)
- 8.3.3 Europe AI Disease Detection Market Share by Application (2021-2032)
- 8.4 Europe AI Disease Detection Market Size by Country
- 8.4.1 Europe AI Disease Detection Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Disease Detection Market Size by Country (2021-2026)
- 8.4.3 Europe AI Disease Detection Market Size by Country (2027-2032)
- 8.4.4 Europe AI Disease Detection Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Disease Detection Market Size (2021-2032)
- 9.2 China AI Disease Detection Market Size by Type
- 9.2.1 China AI Disease Detection Market Size by Type (2021-2026)
- 9.2.2 China AI Disease Detection Market Size by Type (2027-2032)
- 9.2.3 China AI Disease Detection Market Share by Type (2021-2032)
- 9.3 China AI Disease Detection Market Size by Application
- 9.3.1 China AI Disease Detection Market Size by Application (2021-2026)
- 9.3.2 China AI Disease Detection Market Size by Application (2027-2032)
- 9.3.3 China AI Disease Detection Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Disease Detection Market Size (2021-2032)
- 10.2 Asia AI Disease Detection Market Size by Type
- 10.2.1 Asia AI Disease Detection Market Size by Type (2021-2026)
- 10.2.2 Asia AI Disease Detection Market Size by Type (2027-2032)
- 10.2.3 Asia AI Disease Detection Market Share by Type (2021-2032)
- 10.3 Asia AI Disease Detection Market Size by Application
- 10.3.1 Asia AI Disease Detection Market Size by Application (2021-2026)
- 10.3.2 Asia AI Disease Detection Market Size by Application (2027-2032)
- 10.3.3 Asia AI Disease Detection Market Share by Application (2021-2032)
- 10.4 Asia AI Disease Detection Market Size by Country
- 10.4.1 Asia AI Disease Detection Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Disease Detection Market Size by Country (2021-2026)
- 10.4.3 Asia AI Disease Detection Market Size by Country (2027-2032)
- 10.4.4 Asia AI Disease Detection Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Disease Detection Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Disease Detection Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Disease Detection Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Disease Detection Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Disease Detection Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Disease Detection Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Disease Detection Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Disease Detection Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Disease Detection Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Disease Detection Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Disease Detection Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Disease Detection Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Disease Detection Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Disease Detection Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst